New Study Reveals Risks Linked to Common IBS Medications

Health Points

• Nearly 670,000 adults were included in a study examining long-term IBS medication use and mortality risk.
• Certain drugs, including loperamide and some antidepressants, showed a small statistical increase in risk.
• Experts stress the findings show correlation, not proof that the medications directly caused the outcomes.

IBS Management and Safety

• Long-term use of specific antidiarrheals and antidepressants was linked to increased risk, while antispasmodics and constipation treatments showed no such association.
• Experts suggest that observations may reflect indirect factors such as higher rates of cardiovascular events, falls, or strokes rather than direct drug toxicity.
• Lifestyle modifications, including the low-FODMAP diet, regular exercise, and stress management, remain the first line of defense for managing IBS symptoms effectively.

“IBS patients should not panic, but they do need to understand and weigh the small but meaningful risks when considering long-term treatments,” said senior study author Dr. Ali Rezaie.

Dr. Rudolph Bedford noted that because IBS symptoms can be painful and debilitating, medications often provide essential benefits that improve a patient’s overall daily function.

Individuals currently managing IBS should consult with their healthcare providers to discuss their specific risk factors and explore a balanced approach to long-term symptom relief.

Common IBS Treatments Higher Risk Early Death